March 15, 2017

Highlights from Breast Cancer Research

 
Breast Cancer Research
Impact Factor: 5.211
Editor-in-Chief: Lewis Chodosh
 
 
Submit Manuscript  |  Editorial Board  |  Submission Guidelines  |  Article Alerts
 

Dear Dr Wirawan,

We would like to share with you some highlights in Breast Cancer Research from January and February. For the full list of articles published in Breast Cancer Research, please visit the journal website.

Featured Articles

Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy
Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2− breast cancer that had progressed during or after prior endocrine therapy

Antonio Musolino et al. report that a potent fibroblast growth factor receptor (FGFR) inhibitor known as dovitinib demonstrated antitumor activity in pretreated patients with FGFR pathway-amplified breast cancer.

Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program

Citing results from a large nested case-control study conducted through a national screening program, Merete Ellingjord-Dale et al. suggest that reproductive factors were associated with all molecular subtypes of breast cancer to some extent, with the strongest trends being found in luminal-like subtypes.

Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis

Data presented by Huiyan Ma et al. indicate that breastfeeding may decrease the risk of triple-negative breast cancer, especially in young African-American women.

Social Media

Follow @BCRjournal on Twitter

Don't forget Breast Cancer Research has its own Twitter account! To stay updated with the latest journal news and content, please follow us and make sure to recommend to your colleagues.

Submit your research

Breast Cancer Research offers fast and thorough peer review, with rapid publication and PubMed indexing after acceptance. All research is open access, giving high visibility to your work.

Why not consider publishing your next research article with Breast Cancer Research? To find out whether your article is suitable for the journal, send a presubmission enquiry to editorial@breast-cancer-research.com.

 
at